Results 101 to 110 of about 48,009 (234)

Psychosocial Outcomes in Patients With Endocrine Tumor Syndromes: A Systematic Review

Pediatric Blood &Cancer, Volume 73, Issue 3, March 2026.
ABSTRACT Introduction The combination of disease manifestations, the familial burden, and varying penetrance of endocrine tumor syndromes (ETSs) is unique. This review aimed to portray and summarize available data on psychosocial outcomes in patients with ETSs and explore gaps and opportunities for future research and care.
Daniël Zwerus, Floortje Strobbe, Annemarie A. Verrijn Stuart, Hanneke M. van Santen, Gerlof D. Valk, Sasja A. Schepers, Rachel S. van Leeuwaarde   +6 more
wiley   +1 more source

Uncommon metastatic journey: unusual breast metastases of medullary thyroid carcinoma: a case report

BMC Women's Health
Medullary thyroid carcinoma is a neuroendocrine tumor derived from thyroid C-cells. It is a rare aggressive tumor, known to metastasize to lymph nodes, liver, bones, and lungs.
Saadallah Fatma, Chrigui Maha, Zemni Ines, Kammoun Salma, Houcin Yoldez, Jbeli Souhail, Driss Maha, Ben Dhiab Tarak   +7 more
doaj   +1 more source

Kinase inhibitors in thyroid cancers

Endocrine Oncology
Objective: The treatment landscape for thyroid cancers has changed rapidly with the availability of kinase inhibitors against VEGFR, BRAF, MEK, NTRK, and RET.
Vineeth Sukrithan, Prachi Jain, Manisha H Shah, Bhavana Konda   +3 more
doaj   +1 more source

Pattern and Clinical Significance of CA19‐9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Carbohydrate antigen 19–9 (CA19‐9) is a cell surface glycoprotein widely used as a diagnostic and prognostic serum marker for monitoring pancreatic cancer. The aim of this study was to evaluate the prevalence and clinical relevance of CA19‐9 expression in human cancer. Methods To comprehensively determine the prevalence and clinical
Nina Schraps, Anne Menz, Florian Viehweger, Seyma Büyücek, David Dum, Ria Schlichter, Andrea Hinsch, Christoph Fraune, Christian Bernreuther, Martina Kluth, Claudia Hube‐Magg, Katharina Möller, Viktor Reiswich, Andreas M. Luebke, Patrick Lebok, Sören Weidemann, Guido Sauter, Maximilian Lennartz, Frank Jacobsen, Till S. Clauditz, Andreas H. Marx, Ronald Simon, Stefan Steurer, Baris Mercanoglu, Nathaniel Melling, Thilo Hackert, Eike Burandt, Natalia Gorbokon, Sarah Minner, Till Krech, Florian Lutz, Morton Freytag   +31 more
wiley   +1 more source

Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer [PDF]

, 2018
Familial aggregation is a significant risk factor for the development of thyroid cancer and Familial Non-Medullary Thyroid Cancer (FNMTC) accounts for 5-7% of all NMTC.
Anbunathan, Hima, Argenton, Francesco, Babbi, Giulia, Bergamini, Christian, BONORA, ELENA, Bowcock, Anne, Casadio, Rita, Costanzini, Anna, Diquigiovanni, Chiara, Evangelisti, Cecilia, Fato, Romana, Iommarini, Luisa, Isidori, Federica, Lenaz, Giorgio, PAGOTTO, UBERTO, Porcelli, Anna Maria, Repaci, Andrea, Rhoden, Kerry J, Romeo, Giovanni, SERI, MARCO, Tiso, Natascia, Vettori, Andrea   +21 more
core   +3 more sources

Thyroid Metastasis From Colorectal Adenocarcinoma: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 3, March 2026.
Positron emission tomography‐computed tomography scan demonstrating thyroid metastasis from colorectal carcinoma in the context of metastatic disease. ABSTRACT Colorectal adenocarcinoma is one of the most common malignancies worldwide. Although metastases typically affect the liver, lungs, and peritoneum, thyroid involvement is extremely rare, with ...
Urías Hernandez Lopez, Pastor Thomas Olivares, Liney Mendoza Suarez, Alejandro Tejada Giraldo, Astrid Del Valle Pestana, Vianeis Caicedo Mora, Audrey Vargas Buelvas   +6 more
wiley   +1 more source

Solid Subtype of Papillary Thyroid Carcinoma: A Case Series Highlighting Aggressive Features

Clinical Case Reports, Volume 14, Issue 3, March 2026.
Hematoxylin and eosin (H&E) stained section, 40×. Tumor cells with “Orphan Annie eye” nuclei arranged in solid nests. ABSTRACT Papillary thyroid carcinoma (PTC) is the most common malignant thyroid neoplasm. Its solid/trabecular subtype (STPTC) is rare, and its aggressiveness remains controversial.
Rafael Castellanos Bueno, Gabriela Almeyda Carreño, Diana Carolina Vergara Arenas, Laura Yibeth Esteban Badillo, Ernesto García Ayala   +4 more
wiley   +1 more source

Cohexisting Medullary and Papillary Thyroid Cancer [PDF]

, 2017
Purpose: Papillary thyroid carcinomas (PTCs) and medullary thyroid carcinomas (MTCs) have always been considered different in terms of their incidence rates, cell origins, and histopathological features.
Dionigi, G., Inversini, D., La Rosa, S., Lavazza, M., Pappalardo, V., Piantanida, E., Sessa, F., Tanda, ML, Uccella, S., Xiaoli, L.   +9 more
core   +2 more sources

Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer

Clinical Endocrinology, EarlyView.
Emma Watts, Jonathan Wadsley, Neil Sharma, Kristien Boelaert, The UK Thyroid Cancer Study Group   +4 more
wiley   +1 more source

An In‐Depth Evaluation of CD15 Expression in Thyroid Carcinoma: A Comprehensive Systematic Review

Cancer Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Cluster of differentiation 15 (CD15) is a carbohydrate epitope implicated in cell adhesion, migration, and tumor progression. It is variably expressed in thyroid carcinoma (TC) subtypes. However, its diagnostic and prognostic value remains uncertain due to methodological heterogeneity and inconsistent findings. Aim To systematically
Amir Ebrahimzadeh Pasha, Amirhossein Ehsani, Sara Ashtari, Mohammad Sadeq Najafi, Bardia Baik, Mohammad Mahdi Mehrabi   +5 more
wiley   +1 more source